These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1618000)

  • 1. Bactericidal activities of ofloxacin and its optically active isomer (DR-3355) on non-growing cells of Escherichia coli and Pseudomonas aeruginosa.
    Tanaka M; Otsuki M; Nishino T
    Chemotherapy; 1992; 38(1):21-7. PubMed ID: 1618000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin.
    Tanaka M; Une T; Osada Y
    Arzneimittelforschung; 1989 Jul; 39(7):750-4. PubMed ID: 2506868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
    Parte AC; Smith JT
    Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of quinolones against slowly growing bacteria.
    Dalhoff A; Matutat S; Ullmann U
    Chemotherapy; 1995; 41(2):92-9. PubMed ID: 7758362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.
    Lewin CS; Amyes SG
    J Med Microbiol; 1989 Nov; 30(3):227-31. PubMed ID: 2479750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the postantibiotic effect of ofloxacin on gram-negative bacteria utilizing a new method.
    Nilsson L; Isaksson B; Maller R; Nilsson M
    J Chemother; 1989 Jul; 1(4 Suppl):149-51. PubMed ID: 16312347
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa.
    Wilkinson JM; Cavanagh HM
    J Med Food; 2005; 8(1):100-3. PubMed ID: 15857217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bactericidal activities of isepamicin and ofloxacin against Pseudomonas aeruginosa evaluated using an in vitro pharmacokinetic simulation system].
    Tsuji A; Kaneko Y; Yamaguchi K; Goto S
    Jpn J Antibiot; 1994 Aug; 47(8):1006-12. PubMed ID: 7933530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa.
    Lamp KC; Rybak MJ; McGrath BJ; Summers KK
    Antimicrob Agents Chemother; 1996 Jan; 40(1):247-52. PubMed ID: 8787917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
    Fujimoto T; Mitsuhashi S
    Chemotherapy; 1990; 36(4):268-76. PubMed ID: 2174762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Monden K; Ando E; Iida M; Kumon H
    J Infect Chemother; 2002 Sep; 8(3):218-26. PubMed ID: 12373484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance studies with ofloxacin.
    Foxall PA; Felmingham D; Grüneberg RN
    J Chemother; 1989 Jul; 1(4 Suppl):381-3. PubMed ID: 16312450
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative antibacterial activity of piperacillin against Pseudomonas aeruginosa, Escherichia coli and Streptococcus faecalis in cultures and human serum].
    Just HM; Reiber T; Bassler M; Daschner FD
    Immun Infekt; 1985 May; 13(3):119-23. PubMed ID: 3924819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Kumon H; Ono N; Iida M; Nickel JC
    Antimicrob Agents Chemother; 1995 May; 39(5):1038-44. PubMed ID: 7625785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of fluoroquinolones in combination with zidovudine.
    Lewin CS; Allen RA; Amyes SG
    J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
    Zeiler HJ; Metzger KG; Schacht P; Grohe K
    Drugs Exp Clin Res; 1985; 11(5):343-50. PubMed ID: 2941263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa.
    O'Driscoll NH; Cushnie TPT; Matthews KH; Lamb AJ
    Arch Microbiol; 2018 Jul; 200(5):793-802. PubMed ID: 29423561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.